Clal Biotechnology Industries Ltd (CBI) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.033x

Based on the latest financial reports, Clal Biotechnology Industries Ltd (CBI) has a cash flow conversion efficiency ratio of -0.033x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million ≈ $-2.85K USD) by net assets (ILA32.60 Million ≈ $87.40K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CBI market cap for the company's overall valuation and market capitalisation.

Clal Biotechnology Industries Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Clal Biotechnology Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clal Biotechnology Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clal Biotechnology Industries Ltd ranked by their cash flow conversion efficiency. Explore Clal Biotechnology Industries Ltd (CBI) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
NanoCMS Co. Ltd. KQ:247660	0.046x
Savannah Goldfields Ltd AU:SVG	-0.584x
Metalsgrove Mining Ltd AU:MGA	-0.095x
Plurilock Security Inc V:PLUR	0.390x
Nur Ink Innovations Ltd TA:NURI	-0.258x
SiamEast Solutions Public Company Limited BK:SE	0.023x
Pudjiadi Prestige Tbk JK:PUDP	0.000x
Alpha Modus Holdings, Inc NASDAQ:AMOD	0.275x

Annual Cash Flow Conversion Efficiency for Clal Biotechnology Industries Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024. View latest Clal Biotechnology Industries Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA46.16 Million ≈ $123.77K	ILA-6.48 Million ≈ $-17.37K	-0.140x	-100.12%
2023-12-31	ILA121.41 Million ≈ $325.49K	ILA-8.51 Million ≈ $-22.82K	-0.070x	+82.79%
2022-12-31	ILA144.90 Million ≈ $388.46K	ILA-59.04 Million ≈ $-158.28K	-0.407x	-233.60%
2021-12-31	ILA338.37 Million ≈ $907.16K	ILA-41.33 Million ≈ $-110.80K	-0.122x	-88.87%
2020-12-31	ILA513.79 Million ≈ $1.38 Million	ILA-33.23 Million ≈ $-89.08K	-0.065x	-219.11%
2019-12-31	ILA497.85 Million ≈ $1.33 Million	ILA27.03 Million ≈ $72.46K	0.054x	+154.16%
2018-12-31	ILA867.62 Million ≈ $2.33 Million	ILA-86.98 Million ≈ $-233.19K	-0.100x	+11.36%
2017-12-31	ILA808.20 Million ≈ $2.17 Million	ILA-91.41 Million ≈ $-245.05K	-0.113x	+24.44%
2016-12-31	ILA752.50 Million ≈ $2.02 Million	ILA-112.63 Million ≈ $-301.97K	-0.150x	-11.24%
2015-12-31	ILA1.09 Billion ≈ $2.93 Million	ILA-147.00 Million ≈ $-394.10K	-0.135x	-46.12%
2014-12-31	ILA1.26 Billion ≈ $3.38 Million	ILA-115.95 Million ≈ $-310.86K	-0.092x	+14.64%
2013-12-31	ILA1.38 Billion ≈ $3.70 Million	ILA-148.98 Million ≈ $-399.40K	-0.108x	-85.31%
2012-12-31	ILA1.40 Billion ≈ $3.74 Million	ILA-81.22 Million ≈ $-217.75K	-0.058x	+37.01%
2011-12-31	ILA1.11 Billion ≈ $2.97 Million	ILA-102.45 Million ≈ $-274.67K	-0.092x	-1.22%
2010-12-31	ILA1.23 Billion ≈ $3.29 Million	ILA-111.93 Million ≈ $-300.07K	-0.091x	+17.70%
2009-12-31	ILA782.91 Million ≈ $2.10 Million	ILA-86.86 Million ≈ $-232.87K	-0.111x	+41.91%
2008-12-31	ILA274.45 Million ≈ $735.80K	ILA-52.41 Million ≈ $-140.52K	-0.191x	-25.63%
2007-12-31	ILA309.49 Million ≈ $829.73K	ILA-47.05 Million ≈ $-126.14K	-0.152x	+24.93%
2006-12-31	ILA116.28 Million ≈ $311.75K	ILA-23.55 Million ≈ $-63.13K	-0.203x	--

About Clal Biotechnology Industries Ltd

TA:CBI Israel Biotechnology

Market Cap

$10.60 Million

ILA3.95 Billion ILA

Market Cap Rank

#26999 Global

#382 in Israel

Share Price

ILA25.20

Change (1 day)

+7.23%

52-Week Range

ILA22.40 - ILA42.50

All Time High

ILA380.64